You are here

BETHESDA PHARMACEUTICALS, INC.

Company Information
Address
BETHESDA PHARMACEUTICALS, INC. 404 WINDSOR PARK DR
BAKERSFIELD, CA 93311 0358
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. New Topical Therapies for Psoriasis

    Amount: $704,066.00

    DESCRIPTION (provided by applicant): Psoriasis is a common, inflammatory disease of the skin characterized by hyperproliferation of keratinocytes. A variety of antipsoriatic therapies are available, h ...

    STTRPhase II2006Department of Health and Human Services National Institutes of Health
  2. New Topical Therapies for Psoriasis

    Amount: $704,066.00

    DESCRIPTION (provided by applicant): Psoriasis is a common, inflammatory disease of the skin characterized by hyperproliferation of keratinocytes. A variety of antipsoriatic therapies are available, h ...

    SBIRPhase II2006Department of Health and Human Services National Institutes of Health
  3. New Topical Therapies for Psoriasis

    Amount: $99,510.00

    DESCRIPTION (provided by applicant): Psoriasis is a common, inflammatory disease of the skin characterized by hyperproliferation of keratinocytes. A variety of antipsoriatic therapies are available, ...

    STTRPhase I2004Department of Health and Human Services National Institutes of Health
  4. New Topical Therapies for Psoriasis

    Amount: $99,510.00

    DESCRIPTION (provided by applicant): Psoriasis is a common, inflammatory disease of the skin characterized by hyperproliferation of keratinocytes. A variety of antipsoriatic therapies are available ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  5. NOVEL THERAPEUTIC APPROACH TO PSORIASIS

    Amount: $315,774.00

    DESCRIPTION (Applicant's abstract): Psoriasis is a common, inflammatory disease of the skin characterized by hyper-proliferation of keratinocytes. A variety of antipsoriatic therapies are av ...

    STTRPhase II2001Department of Health and Human Services National Institutes of Health
  6. NOVEL THERAPEUTIC APPROACH TO PSORIASIS

    Amount: $0.00

    DESCRIPTION (Applicant's abstract): Psoriasis is a common, inflammatory disease of the skin characterized by hyper-proliferation of keratinocytes. A variety of antipsoriatic therapies are av ...

    STTRPhase I2001Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government